Development Pipeline

Next-generation psychedelic and cannabinoid medicines

Enveric has a robust pipeline of short, medium and long-term development programs.

With both psychedelic derived molecules and cannabinoids, we have a robust pipeline to take us from discovery through clinical development. Our platform has the potential to disrupt and unlock much needed mental health treatments through psychedelic therapies. We have brought together pharma and biotech experts with years of experience in bringing innovative treatments to market as well as a discovery team with a world-class biotech laboratory. We are dedicated to our mission to advance the next generation of treatments.

Dr. Joseph TuckerCEO of Enveric

Discovering Next-generation Treatments for the Mind and Body

Our mission is to improve the characteristics of psychedelic- and cannabinoid-derived pharmaceuticals by unlocking their full potential to create treatment solutions for a growing and underserved patient population.